Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.5 USD | +3.02% | +6.41% | +6.74% |
May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.74% | 464M | |
+47.87% | 56.69B | |
-2.80% | 41B | |
+38.14% | 38.11B | |
-11.22% | 26.89B | |
+15.23% | 25.59B | |
-23.11% | 18.59B | |
+0.21% | 12.39B | |
+26.69% | 11.99B | |
+22.77% | 11.88B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- RBC Boosts Price Target on Korro Bio to $90 From $70 on 'Increased Conviction for A1AT,' Keeps Outperform, Speculative Risk